CAC Software vs iCAC Device

Direct competitors — feature-level head-to-head below. Comparability 95/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imbio
VS
by Bunkerhill Health

AI Verdict

Imbio's CAC Software and Bunkerhill Health's iCAC Device are highly comparable, both being FDA-cleared AI tools that detect and quantify coronary artery calcification from non-contrast chest CT scans, providing Agatston scores. While Imbio offers additional outputs like arterial age and 3D visualizations, Bunkerhill Health emphasizes opportunistic identification and EHR integration. Both are direct competitors for automated CAC analysis in cardiology and radiology workflows.

Choose CAC Software if…

Choose Imbio's CAC Software if your institution requires comprehensive, multi-metric quantification and advanced visualization of coronary artery calcification. This tool is ideal for cardiologists and radiologists seeking detailed Agatston scores, arterial age, calcified lesion mass, and 3D visualizations to inform precise risk assessment and treatment planning within a dedicated cardiac imaging workflow.

View CAC Software →

Choose iCAC Device if…

Choose Bunkerhill Health's iCAC Device if your primary goal is opportunistic screening for coronary artery calcium from routine, non-contrast, non-gated chest CT scans already performed for other indications. This solution is well-suited for early cardiovascular disease detection by providing adjunctive information and four-category quantitative estimates of CAC burden, enabling proactive identification of at-risk patients from existing imaging data.

View iCAC Device →

When choosing between Imbio’s CAC Software and Bunkerhill Health’s iCAC Device, physicians should consider their specific workflow and desired level of detail in coronary artery calcification (CAC) analysis. Both tools leverage AI to quantify CAC from non-contrast chest CT scans, aiding in cardiovascular disease risk assessment. The key practical difference lies in the breadth of their output and integration capabilities.

Imbio’s CAC Software offers a more comprehensive suite of metrics, including Agatston score, arterial age, calcified lesion mass and volume, alongside 3D visualizations and annotated images. This makes it ideal for practices seeking in-depth analysis and visual aids for patient communication. Bunkerhill Health’s iCAC Device, while also providing quantitative estimates in Agatston units and visual representations, focuses on opportunistic identification of CAC from existing CT scans and integrates with EHRs via the Carebricks platform.

Therefore, a physician prioritizing detailed, multi-dimensional CAC assessment with advanced visualization and integration into existing DICOM viewing workflows might lean towards Imbio’s CAC Software. Conversely, a physician primarily focused on efficient, opportunistic CAC detection from routine CTs with strong EHR integration for streamlined data flow may find Bunkerhill Health’s iCAC Device to be a more suitable choice.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC Software iCAC Device
Pricing Contact for pricing Contact for pricing
Deployment Cloud, On-premise, Partner platforms Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CAC Software

Tool A emphasizes a fully automated process with no user input or intervention required, integrating seamlessly into existing DICOM viewing workflows without new interfaces to learn. It also provides 3D visualizations and annotated images directly within the workflow, enhancing immediate interpretability for radiologists. Tool B also integrates into existing workflows, but Tool A's explicit claims of minimal user interaction and 'first-read ready' results suggest a slightly more streamlined experience.

Clinical Value

iCAC Device

While both tools are FDA-cleared and provide quantitative CAC scores, Tool B's core strength lies in its explicit focus on 'opportunistic identification' of coronary artery calcium from routine, non-contrast, non-gated chest CT scans. This approach significantly aids early cardiovascular disease detection and population health screening by leveraging existing imaging data without requiring additional dedicated scans. Tool B has also expanded its opportunistic detection capabilities to include aortic valve calcification and bone mineral density, demonstrating a broader clinical impact.

Pricing & Value

Tie

Both Tool A and Tool B state 'contact for pricing' and do not provide any public pricing details or specific value propositions that can be quantitatively compared. Without transparent pricing information, it is impossible to determine which offers better value.

Enterprise Readiness

CAC Software

Tool A explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA) in its structured facts, which are crucial for healthcare enterprise adoption. While Tool B is FDA-cleared and has achieved CMS reimbursement, its HIPAA compliance and BAA details require contacting the vendor, indicating less transparency in the provided information regarding these critical enterprise requirements.

Innovation

iCAC Device

Both tools utilize deep learning, but Tool B demonstrates greater innovation through its strong emphasis on 'opportunistic identification' of CAC from routine CT scans, transforming existing imaging data into a proactive screening opportunity. This innovative approach extends to other conditions like aortic valve calcification and bone mineral density, showcasing a broader vision for leveraging AI for population health within its Carebricks platform.

Support & Docs

CAC Software

Tool A provides clear and detailed information regarding its support structure, including phone and email support, specified support hours (8:00 AM u2013 6:00 PM CST), an online case submission system, and readily available user manuals and FAQs. Tool B's information does not include comparable details about its support channels, hours, or documentation availability.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC Software iCAC Device
Name CAC Software iCAC Device
Company Imbio Bunkerhill Health
Description Automated image post-processing algorithms designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries in patients who have undergone a non-contrast, chest computed tomography (CT). FDA-cleared AI algorithm that detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection.
Key Outputs Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations and annotated images Visual representation of estimated CAC segmentation, exact and four-category quantitative estimates of CAC burden in Agatston units
Input Scan Type Non-contrast, chest computed tomography (CT) Routine, non-contrast, non-gated chest CT scans

Videos

Demos, reviews, and walkthroughs featuring CAC Software and iCAC Device.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio's CAC Software outputs Agatston score, arterial age, calcified lesion mass, and volume metrics for the whole heart and individual coronary artery level. Bunkerhill Health's iCAC Device provides exact and four-category quantitative estimates of CAC burden in Agatston units.
Imbio's CAC Software integrates into existing DICOM viewing workflows and can provide DICOM or PDF summary reports. Bunkerhill Health's iCAC Device integrates with PACS or a DICOM router and can integrate with EHRs via its Carebricks platform.
Imbio's CAC Software provides 3D visualizations and annotated images, including an RGB overlay series showing calcified lesion voxels color-coded by coronary artery. Bunkerhill Health's iCAC Device delivers a visual representation of estimated CAC segmentation.
Imbio's deep-learning based CAC analysis is trained to assess gated or ungated CT scans. Bunkerhill Health's iCAC Device analyzes routine, non-contrast, non-gated chest CT scans.
AI Tool Finder
AI-powered search. Results may not be comprehensive.